Value through Innovation31 July 2014

Boehringer Ingelheim's worldwide Research & Development Sites

At Boehringer Ingelheim, research & development is conducted at three major research & development sites (Biberach and Ingelheim, Germany, Ridgefield, USA, and Vienna, Austria) and two support centres (Kobe, Japan and Milan, Italy). We employ more than 7,000 scientists, technicians and support staff, clinical monitors, statisticians and data managers. Clinical research is conducted in 87 countries all over the world.

The bridge between industry and academia is strengthened by the Research Institute of Molecular Pathology (IMP) in Vienna (Austria)

R&D Sites

Support Centres

Research Areas

Research Areas

Our drug discovery focuses on seven major therapeutic areas.

Basic Research Institute

The Research Institute of Molecular Pathology

Our link to academia and basic research is represented by the IMP.

Research & Development

Research & Development

Oncology Websites

No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player